Pre-operative Screening of Functional Fragilities Before Open Aortic Surgery: a New Area
Launched by UNIVERSITY PAUL SABATIER OF TOULOUSE · Jan 8, 2024
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better prepare patients for open surgery to treat problems with the aorta, such as aneurysms (bulges in the aorta) and blockages. The researchers want to create a new way to assess patients before surgery by looking at their overall health and identifying any weaknesses that could lead to complications after the operation. By gathering information that is already collected during standard care, they hope to develop a risk scale that can help doctors give better guidance and support to patients before their surgery.
To participate in this trial, patients must be scheduled for open aortic surgery in the vascular surgery department. The study is open to all adult patients, and the only reason someone might not be able to join is if they choose to refuse participation. Those who take part can expect to provide information about their health, which will help doctors understand how to improve their recovery and reduce the chance of complications after the surgery. This trial is currently recruiting participants, and the findings could lead to better outcomes for future patients undergoing similar procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients undergoing open aortic surgery in the vascular surgery department
- Exclusion Criteria:
- • patient refusal
About University Paul Sabatier Of Toulouse
The University Paul Sabatier of Toulouse is a leading academic institution in France, renowned for its commitment to advancing medical research and education. With a strong focus on innovation and interdisciplinary collaboration, the university actively sponsors clinical trials that aim to enhance healthcare outcomes and contribute to the scientific community. Its research initiatives are supported by a team of esteemed faculty and researchers, leveraging state-of-the-art facilities and resources to explore cutting-edge treatments and therapies. Through its clinical trial sponsorship, the University Paul Sabatier plays a pivotal role in translating scientific discoveries into real-world applications, ultimately improving patient care and health services.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported